Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

OKYO Pharma shares are trading higher after the company's OK-101 achieved statistical significance for multiple signs and symptoms of dry eye disease in its first-in-human Phase 2 trial.

Author: Benzinga Newsdesk | March 22, 2024 07:12am

Posted In: OKYO